Document is current
Any future updates will be listed below
-
Authors
Visaggi, Pierfrancesco
Ghisa, Matteo
Marabotto, Elisa
Venturini, Arianna
Stefani Donati, Delio
Bellini, Massimo
Savarino, Vincenzo
de Bortoli, Nicola
Savarino, Edoardo https://orcid.org/0000-0002-3187-2894
-
Funding
Funding for this research was provided by:
Università degli Studi di Padova
- License Information
-
More Information
Article History
Received: 13 July 2022
Accepted: 3 October 2022
First Online: 11 October 2022
Declarations
:
: Not applicable.
: PV: none; MG: none; EM: none; AV: none; DSD: none; MB: none; VS has received lecture fees from Reckitt Benkiser, Takeda, Grunenthal, Teofarma, Alfasigma; NdB has received lectures fees from Malesci and Reckitt Benckiser; ES has received lecture or consultancy fees from Abbvie, Alfasigma, Amgen, Aurora Pharma, Bristol-Myers Squibb, EG Stada Group, Fresenius Kabi, Grifols, Janssen, Johnson&Johnson, Innovamedica, Malesci, Medtronic, Merck & Co, Reckitt Benckiser, Sandoz, Shire, SILA, Sofar, Takeda, Unifarco.
